Replies to post #95814 on Biotech Values

[DewDiligence]

AMGN/Denosumab @ASCO: several post-hoc subset and meta-analyses from the three completed studies in metastatic cancer:

http://finance.yahoo.com/news/Amgen-Highlights-Key-Clinical-prnews-2950876243.html?x=0&.v=1

Please see #msg-50215668 for background.

[DewDiligence]

Quiz: #msg-50215668 has a glaring error that I should have caught and readers of the message should have caught. What is it?